Battling Multiple Sclerosis

By Groshan Fabiola

Studies have shown that multiple sclerosis is very hard on people affecting some 2 in every 1000 persons. Even more problematic is the fact that some 50 % of these people are left unable to walk after some 15 from the onset of the disorder. A total cure has not yet been developed but scientists and doctors are working on treatments that will at least slow down the action of the disease. The good thing is that they really are starting to understand how the disorder works and the way it affects people, plus a new kind of monitor treatment is being developed as we speak. The bases for some new treatments have this way been developed; they include the using of disease modifying drugs that will have quite a remarkable impact on the natural course of the disease, significantly slowing it down.

Still some of these drugs are yet to be approved and clinical test are still in progress to really understand if the drugs are working and what the side effects would be. Scientist and doctors from all over the world gather more and more often to discuss their new findings and believes regarding multiple sclerosis. Because of all this effort put into defeating this disease a lot of progress has been made.

More →

Share This

By: Groshan Fabiola

Despite the fact that there is no specific cure for multiple sclerosis in present, existing treatments are effective in slowing down the progression rate of the disease and preventing the development of further complications. Considering the fact that most of the effects of multiple sclerosis are irreversible, it is imperative to timely diagnose the disease and begin the administration of the appropriate course of medications. With the right treatment and with the aid of supportive therapies (physiotherapy and kinetotherapy), patients with multiple sclerosis can regain control of their bodies and live normal, active lives.

The medications available today are used to accomplish a series of goals in patients with multiple sclerosis: some medication treatments are aimed at slowing the progression rate of the disease, while others are aimed at ameliorating its generated symptoms and prolonging the periods of remission. The medications that are nowadays extensively used to delay and control symptomatic flare-ups among patients with multiple sclerosis are known as “ABC drugs”. This category of medications consists of Avonex, Betaseron and Copaxone.

More →

Share This

By Groshan Fabiola

Multiple sclerosis is a disease of the central nervous system that makes it attack the myelin, a substance that protects the nerve endings that are spread throughout the entire body. The central nervous system is responsible for sending the white blood cells and the antibodies attack the viruses and bacteria that threaten to cause infections. When the nervous system is affected by multiple sclerosis it sends these guardian cells against the myelin. The cause of this behavior is not known yet but the scientist believe that it is sometimes genetically-based.

Multiple sclerosis affects more than a million people throughout the world and unfortunately there is no known treatment that can cure it. The only thing that multiple sclerosis therapy can do is to relive its symptoms and modify the way the illness advances and develops.

More →

Share This

By Groshan Fabiola

According to recently conducted experiments, cannabis can be considered an effective remedy for patients diagnosed with multiple sclerosis. While at first the symptomatic improvements experienced by patients with multiple sclerosis who have been administered cannabinoid products were thought to be determined solely by psychological factors, later research has revealed that cannabis actually reduces muscular spasms and stiffness characteristic to multiple sclerosis sufferers. The benefic effects of cannabis on patients with multiple sclerosis have been confirmed by short-term and long-term controlled medical studies.

In 2003, a team of researchers from the Peninsula Medical School in Exeter, UK have made public the results of a series of short-term and long-term studies on the effects of cannabinoids among patients with multiple sclerosis. The previously conducted studies involved the active participation of around 600 patients with advanced-stage multiple sclerosis. The participants were divided in two distinctive groups: the first group received cannabinoid compounds in equal doses, while the second group received placebo medications over a period of 15 weeks. By the end of the experiment, the majority of patients who were administered cannabinoids experienced considerable symptomatic improvements, having less muscular pain and being confronted with milder muscular spasticity (less pronounced muscular spasm). Unlike the group that received cannabinoid compounds over the entire period of the study, the control group (patients who received placebo medications) experienced no improvements in their overall condition.

More →

Share This

By Groshan Fabiola

Despite the fact that there is no specific cure for multiple sclerosis in present, existing treatments are effective in slowing down the progression rate of the disease and preventing the development of further complications. Considering the fact that most of the effects of multiple sclerosis are irreversible, it is imperative to timely diagnose the disease and begin the administration of the appropriate course of medications. With the right treatment and with the aid of supportive therapies (physiotherapy and kinetotherapy), patients with multiple sclerosis can regain control of their bodies and live normal, active lives.

The medications available today are used to accomplish a series of goals in patients with multiple sclerosis: some medication treatments are aimed at slowing the progression rate of the disease, while others are aimed at ameliorating its generated symptoms and prolonging the periods of remission. The medications that are nowadays extensively used to delay and control symptomatic flare-ups among patients with multiple sclerosis are known as “ABC drugs”. This category of medications consists of Avonex, Betaseron and Copaxone.

More →

Share This